BeStock  
Stocks › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2435Biotechnology
$19.91 −$0.09 (-0.45%)
Pre-market · Oct 6, 8:20 am ET · After hours $19.91 0.00%
Open$20.09
Prev close$20.00
Day range$19.54 – $20.09
Volume1.72M
Market cap$3.18B
P/E (TTM)–
Dividend yield–

DNLI Stock News

Headlines matching Denali Therapeutics or the DNLI ticker, most recent first.

  • A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $42Market news · 8 Aug 2026
  • A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $41Market news · 7 Aug 2026
  • B. Riley Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35Market news · 25 Aug 2026
  • J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $29Market news · 11 Aug 2026
  • Morgan Stanley Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $36Market news · 23 Jul 2026
  • Deutsche Bank Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35Market news · 16 Jul 2026
  • BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Announces Target Price $31Market news · 15 Jul 2026
  • J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $29Market news · 13 Jul 2026
  • H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $42Market news · 13 Jul 2026
  • Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $26Market news · 13 Jul 2026
  • UBS Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $25Market news · 16 Jun 2026
  • William Blair Maintains Denali Therapeutics(DNLI.US) With Buy RatingMarket news · 9 May 2026
  • Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), CG Oncology, Inc. (CGON) and Denali Therapeutics (DNLI)TipRanks · 9 May 2026
  • TD Cowen Maintains Denali Therapeutics(DNLI.US) With Buy RatingMarket news · 9 May 2026
  • Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Cuts Target Price to $23Market news · 8 May 2026

Discussion

No comments yet — be the first to weigh in on DNLI.

Leave a comment

Scroll to Top